fate therapeutics stock price target

Wednesday, May 11, 2022 Edit

Sign in to your SmartPortfolio to see more analyst recommendations. FATE analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.

Fate Stock Price And Chart Nasdaq Fate Tradingview

FATE has a greater upside potential average analyst target price relative to current price than 149379 of stocks in the mid market cap category.

. Learn more on FATEs analyst rating history. The average price target is 88928 which means analysts expect the stock to climb by 30294 over the next twelve months. May 6 2022 308 pm.

Find the latest Fate Therapeutics Inc. The average price target represents a 16855 upside from the last price of 3463. 7 2020 at 718 am.

Fate Therapeutics Inc FATE stock is lower by -125 while the SP 500 has risen 02 as of 1104 AM on Tuesday May 10. Is 3589 for 2023 Mar. Stock Price Forecast The 19 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 9000 with a high estimate of 13500 and a low estimate of 4200.

Is 15507 and for 2032 Mar. NASDAQFATEs beta value is currently sitting at 169 while the Average True Range indicator is currently displaying 292. In terms of how Fate Therapeutics Inc fares relative to Pharmaceutical Products stocks note that its average analyst price target is higher than 145991 of that group.

The average twelve-month price target for Fate Therapeutics is 8722 with a high price target of 11600 and a low price target of 6000. Is 13835 for 2027 Mar. Is 13930 for 2031 Mar.

Fate Therapeutics Inc. In the last 3 months 4 analysts have offered 12-month price targets for Fate Therapeutics. FATE has fallen -028 from the previous closing price of 2235 on volume of 492771 shares.

On average they anticipate Fate Therapeutics stock price to reach 8722 in the next twelve months. Fate Therapeutics reported interim results from 14 patients treated with FT596 an off-the-shelf immunotherapy made of natural killer cells engineered to target CD19. Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of.

The lowest target is 4242 and the highest is 14175. 2 days agoHC Wainwright lowered their target price on shares of Fate Therapeutics from 12200 to 11500 and set a buy rating on the stock in a report on Friday March 4th. With analysts defining 4200-13500 as the low and high price targets we arrive at a consensus price target of 8626 for the trailing 12-month period.

5 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 9360 with the highest FATE stock price forecast at 11500 and the lowest FATE stock price forecast at 7400. Based On Fundamental Analysis. Ad Our Strong Buys Double the SP.

Nasdaq AT CLOSE 400 PM EDT 050622. 47 rows Close price at the end of the last trading day Friday 6th May 2022 of. The company has an average price target.

Find the latest Fate Therapeutics Inc. The average price target is 9300 with a high forecast of 14500 and a low forecast of 6000. Is 1761 for 2026 Mar.

This chart shows the closing price for FATE. Price Price Target Lowest. This suggests a possible upside of 2673 from the stocks current price.

This price target is based on 10 analysts offering 12 month price targets for Fate Therapeutics in the last 3 months. FATE stock quote history news and other vital information to help you with your stock trading and investing. Stock Price Forecast According to 26 stock analysts the average 12-month stock price forecast for FATE stock is 9373 which predicts an increase of 28796.

Fate Therapeutics stock price target raised to 88 from 55 at Wedbush Dec. 9 brokerages have issued twelve-month price targets for Fate Therapeutics shares. 13000 The average price target includes all analyst analysis not just the most recent analysis presented in the chart.

AFTER HOURS 717 PM EDT 050622. The average price target is 000 with a high estimate of 000 and a low estimate of 000. According to the issued ratings of 9 analysts in the last year the consensus rating for Fate Therapeutics stock is Buy based on the current 2 hold ratings and 7 buy ratings for FATE.

Their forecasts range from 6000 to 11600. Fate Therapeutics Stock Forecast 05-03-2022. Forecast target price for 05-03-2022.

ET by Tomi Kilgore Fate Therapeutics stock price target raised to 65 from 40 at Truist. Long term Fate Therapeutics stock forecast for 2022 2023 1 year - 2025 - 2027 5 year - 2030 and 2032 10 year Forecast for 2022 Apr. Fate Therapeutics Inc.

Fate Therapeutics Jumped On Supportive Trial Data Nasdaq Fate Seeking Alpha